Hemangioma of the Urinary Bladder: A Brief Narrative Review of Their Diagnosis, Histology, and Treatment Options
Urologia Internationalis · 2024 · 108 (2) · 83-88
DOI: 10.1159/000536057 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Urologia Internationalis, online erschienen am 16.01.2024. Verfasst von Radion Garaz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital of Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Hemangioma, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background: Hemangioma of the urinary bladder is a rare benign tumor. Although benign, their presenting symptoms are alarming for both patients and doctors, and their rarity makes them challenging to correctly diagnosis and treat. This review paper summarizes current knowledge about hemangioma of the urinary bladder, treatment options, and follow-up modalities. Summary: After the kidney, the bladder is the second most common location of hemangiomas in the urinary tract. There is painless gross hematuria on clinical presentation once the lesion has eroded the urothelium. Magnetic resonance imaging (MRI) has been reported to be valuable in diagnosing soft-tissue hemangiomas. Cystoscopic findings of a sessile, blue, multilocular mass suggest hemangioma. Most tumors are solitary, smaller than 3 cm, and have smooth or irregular surfaces. Histologically, lesions comprise numerous proliferative capillaries with thin-walled, dilated, blood-filled vessels lined with flattened endothelium. The treatment of patients with hemangioma has been controversial. It depends on the tumor size and the degree of penetration. The prognosis of these tumors is excellent. Key Messages: Despite the widespread use of MRI, CT, and endoscopy in evaluating hematuria, hemangioma remains one of the rarest bladder tumors. Moreover, only a histological examination can confirm the diagnosis. Transurethral resection, fulguration, and YAG laser ablation are standard treatments for small tumors. In terms of follow-up, cystoscopy after 6 months of treatment helps assess recurrence. In addition, MRI is a practical, noninvasive technique for follow-up of small hemangiomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University Hospital of Tübingen, Tübingen, Germany.
- Department of Pathology, University Hospital Tübingen, Tübingen, Germany.
Zitieren
APA
Garaz, R., Stühler, V., Stenzl, A., Rottscholl, R., & Amend, B. (2024). Hemangioma of the Urinary Bladder: A Brief Narrative Review of Their Diagnosis, Histology, and Treatment Options. Urologia Internationalis, 108(2), 83-88. https://doi.org/10.1159/000536057
Vancouver
Garaz R, Stühler V, Stenzl A, Rottscholl R, Amend B. Hemangioma of the Urinary Bladder: A Brief Narrative Review of Their Diagnosis, Histology, and Treatment Options. Urologia Internationalis. 2024;108(2):83-88. doi:10.1159/000536057
BibTeX
@article{Garaz2024,
author = {Garaz, Radion and Stühler, Viktoria and Stenzl, Arnulf and Rottscholl, Robert and Amend, Bastian},
title = {Hemangioma of the Urinary Bladder: A Brief Narrative Review of Their Diagnosis, Histology, and Treatment Options},
journal = {Urologia Internationalis},
year = {2024},
volume = {108},
number = {2},
pages = {83--88},
doi = {10.1159/000536057}
}
EUVIMED